SecBot SecBot
SECBOTREPLAY Home › Report › CGON

CGON · CG Oncology filed a definitive proxy statement (DEFA14A) for its…

CG Oncology, Inc. · DEFA14A filed Apr 24, 2026 at 16:31 ET

At the news

NEUTRALIMPACT 3/10

DEFA14A filed Apr 24, 2026 at 16:31 ET

CG Oncology filed a definitive proxy statement (DEFA14A) for its upcoming shareholder meeting. This filing follows the recent appointment of Jim DeTore as CFO, which occurred near the same time as this proxy statement. The filing is routine and contains standard proxy information.

  • CG Oncology filed a definitive proxy statement (DEFA14A) for its shareholder meeting.
  • The filing follows the recent appointment of Jim DeTore as CFO, which occurred 11 days prior.
  • The filing is a standard proxy statement with no indication of an activist campaign or contested vote.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access